Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsuyoshi Fukuda

Showing results (61-70 of 111) with videos related to

Pageof 12
Sort By:
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 6, 2002
Myocardial ischemia in Kawasaki disease: evaluation with dipyridamole stress technetium 99m tetrofosmin scintigraphyTsuyoshi Fukuda, Masatoshi Ishibashi, Tatsuo Yokoyama, et al.
Therapeutic Drug Monitoring|April 18, 2014
Effects of unbound mycophenolic acid on inosine monophosphate dehydrogenase inhibition in pediatric kidney transplant patientsThomas A Smits, Shareen Cox, Tsuyoshi Fukuda, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 8, 2008
Antidepressant response and intolerance to SSRI is not influenced by G-protein beta3 subunit gene C825T polymorphism in Japanese major depressive patientsMasaki Kato, Masataka Wakeno, Gaku Okugawa, et al.
European Journal of Clinical Pharmacology|July 14, 2012
Decreased vancomycin clearance in patients with congestive heart failureYuko Shimamoto, Tsuyoshi Fukuda, Shinjiro Tominari, et al.
Peptides|August 13, 2005
Expression of urocortin 3/stresscopin in human adrenal glands and adrenal tumorsKazuhiro Takahashi, Kazuhito Totsune, Masayuki Saruta, et al.
International Clinical Psychopharmacology|April 7, 2005
Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphismMasaki Kato, Yuka Ikenaga, Masataka Wakeno, et al.
Biochimica Et Biophysica Acta|November 15, 2002
Taurine modulates induction of cytochrome P450 3A4 mRNA by rifampicin in the HepG2 cell lineHideyasu Matsuda, Kayoko Kinoshita, Akihiko Sumida, et al.
British Journal of Clinical Pharmacology|June 28, 2021
Model-informed precision dosing for alemtuzumab in paediatric and young adult patients undergoing allogeneic haematopoietic cell transplantationMin Dong, Chie Emoto, Tsuyoshi Fukuda, et al.
Pediatric Blood & Cancer|February 17, 2017
Developmental pharmacokinetics of sirolimus: Implications for precision dosing in neonates and infants with complicated vascular anomaliesTomoyuki Mizuno, Tsuyoshi Fukuda, Chie Emoto, et al.
Inflammatory Bowel Diseases|July 10, 2019
Improved Population Pharmacokinetic Model for Predicting Optimized Infliximab Exposure in Pediatric Inflammatory Bowel DiseaseLaura E Bauman, Ye Xiong, Tomoyuki Mizuno, et al.
Pageof 12

Showing results (61-70 of 111) with videos related to

Sort By:
Pageof 12
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 6, 2002
Myocardial ischemia in Kawasaki disease: evaluation with dipyridamole stress technetium 99m tetrofosmin scintigraphyTsuyoshi Fukuda, Masatoshi Ishibashi, Tatsuo Yokoyama, et al.
Therapeutic Drug Monitoring|April 18, 2014
Effects of unbound mycophenolic acid on inosine monophosphate dehydrogenase inhibition in pediatric kidney transplant patientsThomas A Smits, Shareen Cox, Tsuyoshi Fukuda, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 8, 2008
Antidepressant response and intolerance to SSRI is not influenced by G-protein beta3 subunit gene C825T polymorphism in Japanese major depressive patientsMasaki Kato, Masataka Wakeno, Gaku Okugawa, et al.
European Journal of Clinical Pharmacology|July 14, 2012
Decreased vancomycin clearance in patients with congestive heart failureYuko Shimamoto, Tsuyoshi Fukuda, Shinjiro Tominari, et al.
Peptides|August 13, 2005
Expression of urocortin 3/stresscopin in human adrenal glands and adrenal tumorsKazuhiro Takahashi, Kazuhito Totsune, Masayuki Saruta, et al.
International Clinical Psychopharmacology|April 7, 2005
Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphismMasaki Kato, Yuka Ikenaga, Masataka Wakeno, et al.
Biochimica Et Biophysica Acta|November 15, 2002
Taurine modulates induction of cytochrome P450 3A4 mRNA by rifampicin in the HepG2 cell lineHideyasu Matsuda, Kayoko Kinoshita, Akihiko Sumida, et al.
British Journal of Clinical Pharmacology|June 28, 2021
Model-informed precision dosing for alemtuzumab in paediatric and young adult patients undergoing allogeneic haematopoietic cell transplantationMin Dong, Chie Emoto, Tsuyoshi Fukuda, et al.
Pediatric Blood & Cancer|February 17, 2017
Developmental pharmacokinetics of sirolimus: Implications for precision dosing in neonates and infants with complicated vascular anomaliesTomoyuki Mizuno, Tsuyoshi Fukuda, Chie Emoto, et al.
Inflammatory Bowel Diseases|July 10, 2019
Improved Population Pharmacokinetic Model for Predicting Optimized Infliximab Exposure in Pediatric Inflammatory Bowel DiseaseLaura E Bauman, Ye Xiong, Tomoyuki Mizuno, et al.
Pageof 12